|
 |
|
Home > In Vitro Diagnostics |
|
|
|
|
In Vitro Diagnostics Market Research Reports |
Germany Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
This new report from VPGMarketResearch.com contains 523 pages, 64 tables, and presents a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including:
|
 |
|
$3850.00 |
|
|
|
|
Italy Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
This new report from VPGMarketResearch.com's contains 521 pages, 63 tables, and presents a comprehensive analysis of the Italian hospital clinical chemistry and immunodiagnostics market, including:
|
 |
|
$3850.00 |
|
|
|
|
Spain Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
This new report from VPGMarketResearch.com's contains 514 pages, 63 tables, and presents a comprehensive analysis of the Spanish hospital clinical chemistry and immunodiagnostics market, including:
|
 |
|
$3850.00 |
|
|
|
|
UK Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
This new report from VPGMarketResearch.com's contains 523 pages, 64 tables, and presents a comprehensive analysis of the UK hospital clinical chemistry and immunodiagnostics market, including:
|
 |
|
$3850.00 |
|
|
|
|
Clinical Chemistry and Immunodiagnostic Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
This 320-page report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused Drug assays, including listings of companies developing or marketing new technologies and products.
|
 |
|
$3850.00 |
|
|
|
|
Clinical Chemistry and Immunodiagnostic Laboratory and POC Instrumentation, and Strategic Profiles of Leading Suppliers
This 68-page report reviews operating characteristics and features of high-, medium-, and low-volume/POC clinical chemistry and immunodiagnostic systems.
|
 |
|
$3850.00 |
|
|
|
|
Clinical Chemistry and Immunodiagnostic Technologies, and Strategic Profiles of Leading Suppliers
This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and others.
|
 |
|
$3850.00 |
|
|
|
|
Emerging Molecular Diagnostics Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
This report presents an overview of the clinical significance and market needs for major current and emerging tests, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.
|
 |
|
$3850.00 |
|
|
|
|
Emerging Molecular Diagnostic Technologies and Strategic Profiles of Leading Suppliers
This report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.
|
 |
|
$3850.00 |
|
|
|
|
Molecular Diagnostic Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
This report presents an overview of the clinical significance and market needs for major current and emerging tests, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.
|
 |
|
$3850.00 |
|
|
|
|
Molecular Diagnostic Instrumentation and Strategic Profiles of Leading Suppliers
This report is designed to help suppliers identify and evaluate emerging opportunities for further automating NAT methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e....
|
 |
|
$3850.00 |
|
|
|
|
Molecular Diagnostic Technologies and Strategic Profiles of Leading Suppliers
This report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.
|
 |
|
$3850.00 |
|
|
|
|
France Molecular Diagnostic Product Suppliers--Sales and Market Shares by Test
This unique report from VPGMarketResearch.com provides France sales and market share estimates for major suppliers of molecular diagnostic products....
|
 |
|
$3850.00 |
|
|
|
|
Germany Molecular Diagnostic Product Suppliers--Sales and Market Shares by Test
This unique report from VPGMarketResearch.com provides Germany sales and market share estimates for major suppliers of molecular diagnostic products....
|
 |
|
$3850.00 |
|
|
|
|
Molecular Diagnostics Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country.
|
 |
|
$3850.00 |
|
|
|
|
US Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
Highlights - Comprehensive analysis of the US tumor marker testing market.
- Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years....
|
 |
|
$3850.00 |
|
|
|
|
Tumor Markers: US, Europe, Japan--Strategic Profiles of Leading Cancer Diagnostic Reagent and Instrument Suppliers, Country Volume and Sales Forecasts
This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country. The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
|
 |
|
$3850.00 |
|
|
|
|
Tumor Markers, and Strategic Profiles of Leading Reagent and Instrument Suppliers
This report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
|
 |
|
$3850.00 |
|
|
|
|
|